DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative) - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Nov. 17, 2023 |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
|
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gain on exercise of series B warrants | $ 165,355 | $ 0 | ||
Series A And B Warrants [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Stock issuance costs | $ 1,451,249 | |||
Series A Warrants [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gross proceeds from issuance of equity | $ 10,990,530 | |||
Series B Warrants [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gross proceeds from issuance of equity | $ 3,345,961 | |||
May 2023 Warrants [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gain on fair value of conversion features | $ 5,107,794 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|